In Q2 fiscal 2026 (the quarter ended June 30, 2026), Idexx Laboratories's largest business segment was Companion Animal Group, with $1.12 billion or 92% of revenue, up 9.4% from a year earlier. Next: Water (5%) and Livestock and Poultry Diagnostics (3%).
By product or service, Product brought in 59% and Service brought in 41% of revenue in Q2 fiscal 2026.
By region, United States brought in 64%, EMEA brought in 22% and Asia Pacific brought in 8% of revenue in Q2 fiscal 2026.
From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q3 fiscal 2017.

Fiscal quarters, from company filings
| Business segment | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Companion Animal Group | $1.1B | $1.1B | $1.0B | $1.0B | 92% |
| Water | $58.6M | $50.3M | $54.3M | $51.0M | 5% |
| Livestock and Poultry Diagnostics | $35.2M | $32.5M | $33.9M | $31.8M | 3% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
| Product or service | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Product | $718.6M | $666.1M | $656.2M | $657.6M | 59% |
| Service | $498.0M | $474.7M | $449.1M | $451.9M | 41% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
| Region | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| United States | $773.0M | $725.2M | $705.0M | $717.9M | 64% |
| EMEA | $265.5M | $257.1M | $245.1M | $233.3M | 22% |
| Asia Pacific | $101.5M | $94.4M | $90.7M | $89.3M | 8% |
| Canada | $50.8M | $40.9M | $41.4M | $46.7M | 4% |
| Latin American and Caribbean | $25.8M | $23.2M | $23.0M | $22.3M | 2% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Companion Animal Group, Water and Livestock and Poultry Diagnostics (as reported for Q2 fiscal 2026).
Companion Animal Group: $1.12 billion, or 92% of revenue, in Q2 fiscal 2026.
By revenue in Q2 fiscal 2026: Product (59%) and Service (41%).
By region in Q2 fiscal 2026: United States (64%), EMEA (22%), Asia Pacific (8%) and Canada (4%).
Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i
Fiscal quarter ended Jun 30, 2026
| Item | Revenue | Share |
|---|---|---|
| Companion Animal Group | USD 1.12B | 92.3% |
| Water | USD 58.56M | 4.8% |
| Livestock and Poultry Diagnostics | USD 35.18M | 2.9% |
| Corporate and otheri | USD 4.60M |
Sum of items USD 1.21B; corporate items and eliminations USD 4.60M. Shares are of the items shown. Click an item with › to see its parts.
Every item and period in one grid. Purple = calculated; "–" = not available.
| Item | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 | Q4 FY23 | Q3 FY23 | Q2 FY23 | Q1 FY23 | Q4 FY22 | Q3 FY22 | Q2 FY22 | Q1 FY22 | Q4 FY21 | Q3 FY21 | Q2 FY21 | Q1 FY21 | Q4 FY20 | Q3 FY20 | Q2 FY20 | Q1 FY20 | Q4 FY19 | Q3 FY19 | Q2 FY19 | Q1 FY19 | Q4 FY18 | Q3 FY18 | Q2 FY18 | Q1 FY18 | Q4 FY17 | Q3 FY17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Companion Animal Group | 1.1B | 1.1B | 998.5M | 1.0B | 1.0B | 919.8M | 870.5M | 892.0M | 922.3M | 889.3M | 821.3M | 837.2M | 866.7M | 827.3M | 748.5M | 765.0M | 784.1M | 761.2M | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Cag | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 732.5M | 745.6M | 692.8M | – | 638.0M | 566.1M | 552.0M | 529.8M | 533.1M | 547.3M | 508.9M | 479.0M | 478.1M | 507.5M | 470.8M | – | 426.7M |
| Water | 58.6M | 50.3M | 50.5M | 54.3M | 51.0M | 45.3M | 45.2M | 50.2M | 46.7M | 43.1M | 41.8M | 44.5M | 43.0M | 38.9M | 39.3M | 40.8M | 39.2M | 36.4M | – | 38.1M | 37.2M | 34.0M | – | 33.3M | 28.1M | 34.1M | 32.9M | 34.9M | 34.8M | 30.3M | 30.3M | 33.1M | 32.7M | 29.1M | – | 31.0M |
| Livestock and Poultry Diagnostics | 35.2M | 32.5M | 37.5M | 33.9M | 31.8M | 28.6M | 34.6M | 29.0M | 30.3M | 28.2M | 32.8M | 29.7M | 29.9M | 29.2M | 33.4M | 28.5M | 29.9M | 30.9M | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Lpd | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 29.1M | 33.5M | 39.3M | – | 37.0M | 32.2M | 34.2M | 36.7M | 31.4M | 33.1M | 31.5M | 33.9M | 29.4M | 35.0M | 32.2M | – | 28.4M |
| Other | – | – | – | – | – | – | – | 4.4M | 4.2M | 3.5M | 5.8M | 4.2M | 4.0M | 4.8M | 7.3M | 7.4M | 7.4M | 8.1M | – | 10.7M | 9.8M | 11.6M | – | 13.5M | 11.1M | 6.0M | 6.1M | 5.9M | 4.9M | 5.3M | 6.2M | 4.8M | 5.6M | 5.4M | – | 5.9M |
| Corporate and other | 4.6M | 4.0M | – | 4.5M | 4.3M | 4.7M | 4.1M | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |